Self-reported Cannabidiol (CBD) Use for Conditions With Proven Therapies

被引:33
|
作者
Leas, Eric C. [1 ]
Hendrickson, Erik M. [1 ,2 ]
Nobles, Alicia L. [1 ,3 ]
Todd, Rory [1 ]
Smith, Davey M. [3 ]
Dredze, Mark [4 ]
Ayers, John W. [1 ,3 ]
机构
[1] Univ Calif San Diego, Ctr Data Driven Hlth, Qualcomm Inst, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA
[3] Univ Calif San Diego, Dept Med, Div Infect Dis & Global Publ Hlth, La Jolla, CA 92093 USA
[4] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA
关键词
SOLD;
D O I
10.1001/jamanetworkopen.2020.20977
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Question Is the public using cannabidiol (CBD) to treat diagnosable conditions that have evidence-based therapies? Findings In this case series of 376 posts on a CBD forum on Reddit, most users reported taking CBD as a therapeutic for diagnosable conditions, including mental health, cardiological, dermatological, gastroenterological, ophthalmological, oral health, and sexual health conditions, many of which have other evidence-based treatment regimens. Meaning The findings suggest a need for interventions that address the use of CBD for unproven applications, including regulating therapeutic claims about CBD and redirecting patients to proven therapies in lieu of CBD. Importance Use of cannabidiol (CBD) has markedly increased in the past 5 years, concurrent with marketing claims that over-the-counter CBD can be used to treat almost any health condition. However, the reasons why individuals use CBD remain unclear. Objective To assess whether individuals are using CBD for diagnosable conditions that have evidence-based therapies. Design, Setting, and Participants This case series assessed claimed treatment applications reported by CBD users in public testimonials shared on the Reddit forum r/CBD. The r/CBD forum was selected because it includes a large, naturally occurring sample of 104917 registered individuals who publicly discuss their experiences using CBD. All r/CBD posts were obtained from January 1, 2014, through August 31, 2019. A random sample of posts was drawn (n = 3000) and filtered to include posts in which self-identified CBD users testified why they take CBD (n = 376). Exposures Self-reported use of CBD for medicinal purposes. Main Outcomes and Measures Cannabidiol testimonials were divided into 11 subcategories corresponding with the condition's medical subspecialty and 2 subcategories corresponding with wellness benefits. Posts were allowed to receive more than 1 label. Results Of the 376 posts labeled as testimonials, 90.0% (95% CI, 86.8%-92.8%) of testimonials claimed that CBD treated the individual's diagnosable conditions. Psychiatric conditions (eg, autism or depression) were the most frequently cited subcategory, mentioned in 63.9% (95% CI, 59.0%-69.1%) of testimonials, followed by orthopedic (26.4%; 95% CI, 21.8%-31.1%), sleep (14.6%; 95% CI, 11.3%-18.5%), and neurological (6.9%; 95% CI, 4.4%-9.6%) conditions. Testimonials also claimed that CBD treated gastroenterological conditions (3.9%; 95% CI, 1.9%-6.1%), as well as addiction, cardiological, dermatological, ophthalmological, oral health, and sexual health conditions (<2.0% each). By contrast, just 29.5% (95% CI, 24.8%-34.2%) of testimonies claimed any wellness benefit, with most citing mental wellness (eg, "quieting my mind") (29.5% [95% CI, 24.2%-34.4%]); 1.4% (95% CI, 0.3%-2.8%) claimed a physical wellness benefit (eg, "exercise performance"). Conclusions and Relevance The findings of this case series suggest a need for regulation of factors associated with CBD being used to treat diagnosable conditions, engagement of health care professionals with patients on their potential CBD use, and implementation of public health campaigns that encourage the public to seek treatment advice from health care professionals regarding evidence-based therapies. This case series assesses whether individuals are using cannabidiol (CBD) to treat diagnosable conditions with proven therapies.
引用
下载
收藏
页数:8
相关论文
共 50 条
  • [41] Reliability of proxy-reported and self-reported household appliance use
    Mills, KM
    Kheifets, LI
    Nelson, LM
    Bloch, DA
    Takemoto-Hambleton, R
    Kelsey, JL
    EPIDEMIOLOGY, 2000, 11 (05) : 581 - 588
  • [42] Methotrexate Use in Patients: Self-Reported Coping Mechanisms
    Richards, Dawn
    Proulx, Laurie
    Wilhelm, Linda
    Robertson, Nathalie
    McKinnon, Annette
    Gunderson, Janet
    Mohoruk, Don
    JOURNAL OF RHEUMATOLOGY, 2017, 44 (06) : 861 - 861
  • [43] Self-reported strategy use in working memory tasks
    Ritakallio, Liisa
    Fellman, Daniel
    Salmi, Juha
    Jylkka, Jussi
    Laine, Matti
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [44] Alcohol use and self-reported violent events in Chile
    Castillo-Carniglia, Alvaro
    Pizarro, Esteban
    Luengo, Daniela
    Soto-Brandt, Gonzalo
    ADICCIONES, 2014, 26 (01) : 46 - 53
  • [45] Accuracy of self-reported healthcare use in patients with osteoarthritis
    Cronan, TA
    Walen, HR
    JOURNAL OF RHEUMATOLOGY, 2002, 29 (10) : 2181 - 2184
  • [46] THE VALIDITY OF SELF-REPORTED CONDOM USE AMONG ADOLESCENTS
    SHEW, ML
    REMAFEDI, G
    RESNICK, M
    BEARINGER, LH
    JOURNAL OF ADOLESCENT HEALTH, 1995, 16 (02) : 157 - 157
  • [47] Self-reported inner speech use in university students
    Morin, Alain
    Duhnych, Christina
    Racy, Famira
    APPLIED COGNITIVE PSYCHOLOGY, 2018, 32 (03) : 376 - 382
  • [48] SELF-REPORTED USE OF COMMUNICATION TECHNIQUES IN THE EMERGENCY DEPARTMENT
    McCarthy, Danielle M.
    Cameron, Kenzie A.
    Courtney, D. Mark
    Vozenilek, John A.
    JOURNAL OF EMERGENCY MEDICINE, 2012, 43 (05): : E355 - E361
  • [49] THE VALIDITY OF SELF-REPORTED DATA ON DRUG-USE
    HARRISON, LD
    JOURNAL OF DRUG ISSUES, 1995, 25 (01) : 91 - 111
  • [50] Self-reported handheld device use while driving
    Kim, Karl
    Ghimire, Jiwnath
    Pant, Pradip
    Yamashita, Eric
    ACCIDENT ANALYSIS AND PREVENTION, 2019, 125 : 106 - 115